These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25855929)

  • 1. RLN2 regulates in vitro invasion and viability of osteosarcoma MG-63 cells via S100A4/MMP-9 signal.
    Ren XF; Zhao H; Gong XC; Wang LN; Ma JF
    Eur Rev Med Pharmacol Sci; 2015; 19(6):1030-6. PubMed ID: 25855929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of relaxin-2 and S100A4 expression in osteosarcoma.
    Huang H; Zheng HY; Liu ZL; Zhang L
    Eur Rev Med Pharmacol Sci; 2014 Oct; 18(19):2828-34. PubMed ID: 25339476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERK5 silencing inhibits invasion of human osteosarcoma cell via modulating the Slug/MMP-9 pathway.
    Yue B; Ren QX; Su T; Wang LN; Zhang L
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2640-7. PubMed ID: 25317798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking TGF-β inhibits breast cancer cell invasiveness via ERK/S100A4 signal.
    Wang XG; Meng Q; Qi FM; Yang QF
    Eur Rev Med Pharmacol Sci; 2014; 18(24):3844-53. PubMed ID: 25555875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.
    Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K
    Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.
    Radestock Y; Hoang-Vu C; Hombach-Klonisch S
    Breast Cancer Res; 2008; 10(4):R71. PubMed ID: 18718015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J; Zhang DL; Jiao XL; Dong Q
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relaxin enhances in-vitro invasiveness of breast cancer cell lines by upregulation of S100A4/MMPs signaling.
    Cao WH; Liu HM; Liu X; Li JG; Liang J; Liu M; Niu ZH
    Eur Rev Med Pharmacol Sci; 2013 Mar; 17(5):609-17. PubMed ID: 23543443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
    Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
    Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9.
    Zhang G; Li M; Jin J; Bai Y; Yang C
    Asian Pac J Cancer Prev; 2011; 12(8):2075-80. PubMed ID: 22292654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme.
    Bjørnland K; Winberg JO; Odegaard OT; Hovig E; Loennechen T; Aasen AO; Fodstad O; Maelandsmo GM
    Cancer Res; 1999 Sep; 59(18):4702-8. PubMed ID: 10493528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A4 promotes squamous cell laryngeal cancer Hep-2 cell invasion via NF-kB/MMP-9 signal.
    Zhang W; Liu Y; Wang CW
    Eur Rev Med Pharmacol Sci; 2014; 18(9):1361-7. PubMed ID: 24867514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNAi-mediated knockdown of relaxin decreases in vitro proliferation and invasiveness of osteosarcoma MG-63 cells by inhibition of MMP-9.
    Ma JF; Liu L; Yang WJ; Zang LN; Xi YM
    Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):1102-9. PubMed ID: 23661525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RLN2 Is a Positive Regulator of AKT-2-Induced Gene Expression Required for Osteosarcoma Cells Invasion and Chemoresistance.
    Ma J; Huang H; Han Z; Zhu C; Yue B
    Biomed Res Int; 2015; 2015():147468. PubMed ID: 26229955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin--an important downstream effector of S100A4-mediated invasion and metastasis.
    Berge G; Pettersen S; Grotterød I; Bettum IJ; Boye K; Mælandsmo GM
    Int J Cancer; 2011 Aug; 129(4):780-90. PubMed ID: 20957651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
    Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
    Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small interfering RNA-directed knockdown of S100A4 decreases proliferation and invasiveness of osteosarcoma cells.
    Ma X; Yang Y; Wang Y; An G; Lv G
    Cancer Lett; 2010 Dec; 299(2):171-81. PubMed ID: 20855150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paris saponin VII suppresses osteosarcoma cell migration and invasion by inhibiting MMP‑2/9 production via the p38 MAPK signaling pathway.
    Cheng G; Gao F; Sun X; Bi H; Zhu Y
    Mol Med Rep; 2016 Oct; 14(4):3199-205. PubMed ID: 27572907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRAME promotes in vitro leukemia cells death by regulating S100A4/p53 signaling.
    Xu Y; Rong LJ; Meng SL; Hou FL; Zhang JH; Pan G
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1057-63. PubMed ID: 27049257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of Ether à go-go 1 and its molecular mechanism of regulating the malignant phenotype of osteosarcoma].
    Chen ZD; Liu QJ; Zeng WR; Wu XY; Lin B; Wu J
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):818-825. PubMed ID: 27998439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.